3/8/2013

A round of Series C financing headed by Novo Ventures has pulled in $48 million for Nevro. The Menlo Park, Calif.-based company, which focuses on a device to treat chronic back pain, will use the money to finance its product development and commercialization, CEO Michael Demane said.

Related Summaries